JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $43
TG Therapeutics Analyst Ratings
AMC Theatres Achieves Record Domestic Revenue Pre-Thanksgiving Weekend With 4.6M Moviegoers, Driven by WICKED and GLADIATOR II, ODEON's Single-Day High, Nearly Sold-Out WICKED Merchandise, and Anticipates Upcoming WICKED Singalong Showtimes; No...
Select Medical Hldgs Analyst Ratings
Hospitals Lowered at Wells Fargo After Republican Sweep
FDA Approves BridgeBio Pharma's Drug For Rare Heart Disease, Poised To Challenge Pfizer In Lucrative Yet Competitive Market
Janux Therapeutics To Host Virtual Event On Monday, December 2, 2024, At 4:30 PM ET Discussing Updated Clinical Data In Phase 1a Dose Escalation For JANX007 In MCRPC And Doses Selected For Phase 1b Expansion Studies
Loop Capital Maintains Hold on GMS, Raises Price Target to $93
A Look Ahead: Arrowhead Pharma's Earnings Forecast
DA Davidson Maintains Neutral on Helen Of Troy, Raises Price Target to $78
GMS Analyst Ratings
Helen Of Troy Analyst Ratings
This Sarepta Therapeutics Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Jim Cramer: Copart Is 'Remarkable,' BHP Is 'Well-Run,' Buy This Energy Stock
Natural Grocer Shares Are Trading Higher After the Company Announced Better-than-expected Q4 Financial Results.
D-Wave Quantam Shares Are Trading Higher After AWS Announced Quantum Embark Program.
Wall Street's Most Accurate Analysts Give Their Take On 3 Tech Stocks Delivering High-Dividend Yields
Today's Pre-Market Movers and Top Ratings | MSTR, BBWI, TGT, M and More
Compass Point Maintains Buy on Two Harbors Inv, Lowers Price Target to $14.75
Top 3 Health Care Stocks That May Dip This Month